Sandra Beaver is the Chief Financial Officer at Evolus, Inc., a performance beauty company focused on delivering innovative aesthetic treatments. With over 25 years of experience in financial leadership roles, Sandra has a proven track record of driving growth and profitability for companies across various industries. Prior to joining Evolus in 2020, she served as the CFO of Zynerba Pharmaceuticals, where she played a pivotal role in the company's successful IPO and subsequent financings. Sandra also held senior finance positions at Endo Pharmaceuticals and Sepracor, where she was instrumental in the companies' strategic initiatives and financial planning. At Evolus, Sandra oversees all aspects of the company's financial operations, including accounting, financial planning and analysis, investor relations, and treasury management. Her strategic vision and financial acumen have been instrumental in guiding Evolus through its growth phase, as the company expands its product portfolio and enters new markets. Under her leadership, Evolus has strengthened its financial position, enabling the company to invest in research and development and pursue strategic partnerships to drive long-term value creation. Sandra's achievements extend beyond her role at Evolus. She is a recognized leader in the financial community, frequently sharing her insights on industry trends and best practices. Sandra holds an MBA from Villanova University and a Bachelor of Science in Accounting from Drexel University. Her dedication to excellence and commitment to fostering a culture of transparency and accountability have made her an invaluable asset to Evolus and the broader business community.